EBD GmbH is part of the Knowledge & Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America 2014 EBD Group MassBio

Share/Follow Us

Share this:
Follow this event:
Follow us on Twitter
Subscribe to our newsletters:

Panelists and Advisors

Irene Abrams Irene Abrams
TIDO, Senior Director
Boston Children's Hospital
Richard Andrews Richard Andrews
President and CEO
Thrasos Therapeutics Inc.
Jeffrey   Arnold Jeffrey Arnold
Mass Med Angels and Boston Harbor Angels
Kees Been Kees Been
President and CEO
Lysosomal Therapeutics Inc.
Bruce Booth Bruce Booth
Atlas Venture
Frank Borriello Frank Borriello
VP, Head of Search and Evaluation, Global Business Development
Richard Brudnick Richard Brudnick
VP, Co-Head BD/M&A
Paola Casarosa Paola Casarosa
Corporate VP, Business Development and Licensing/Prescription Medicinces
Boehringer Ingelheim
David J.  Collier David J. Collier
Managing Director
Presidio Partners
Daniel J. Curran
Head, Center for External Innovation
Takeda Pharmaceuticals
Bernard Davitian Bernard Davitian
VP and Managing Director,
Sanofi-Genzyme BioVentures
Christopher de Souza
Broadview Ventures
Pamela Demain Pamela Demain
Executive Director, Business Development and Licensing
Merck & Co. Inc.
Steve Dickman Steve Dickman
CBT Advisors
Deborah Dunsire Deborah Dunsire
President and CEO
FORUM Pharmaceuticals
Chris Gemmiti Chris Gemmiti
Business Development Lead
Wyss Institute for Biologically Inspired Engineering Harvard Unversity
Jeff Goater Jeff Goater
Senior VP, Finance and Business Development
Voyager Therapeutics
John Hallinan John Hallinan
Chief Business Officer
Jeffrey B.  Kindler Jeffrey B. Kindler
Centrexion Corp.
Tomas Landh Tomas Landh
Innovation Sourcing, VP, Senior Principal Scientist
Novo Nordisk
Edward Lanphier Edward Lanphier
President and CEO
Sangamo BioSciences
Jeremy Levin Jeremy Levin
Chairman and CEO
Ovid Therapeutics Inc.
Philippe Lopes-Fernandes Philippe Lopes-Fernandes
Senior VP and Head,
Global Licensing and Business Development
EMD Serono
Douglas MacDougall Douglas MacDougall
MacDougall Biomedical Communications
Ivana Magovcevic-Liebisch Ivana Magovcevic-Liebisch
Senior VP and Head of Global Business Development
Teva Pharmaceuticals
Francois Maisonrouge Francois Maisonrouge
Senior Managing Director
Evercore Partners
Angus McQuilken Angus McQuilken
VP, Marketing and Communications
Massachusetts Life Sciences Center
Robert Millman Robert Millman
CEO, Semma Therapeutics
Managing Director
MPM Capital
Imran Nasrullah Imran Nasrullah
Director, Innovation Sourcing
Boehringer Ingelheim
Marta New Marta New
Baxalta Ventures
Isai Peimer Isai Peimer
Managing Director
MedImmune Ventures
Michal Preminger Michal Preminger
Executive Director
Office of Technology Development
Harvard University
Dennis J. Purcell Dennis J. Purcell
Founder and Senior Advisor
Aisling Capital
Jeffrey L. Quillen Jeffrey L. Quillen
Foley Hoag LLP
Brock Reeve Brock Reeve
Executive Director
Harvard Stem Cell Institute
Greg Robinson Greg Robinson
Chief Scientific Officer
Agilis Biotherapeutics
Gary M.  Sclar Gary M. Sclar
Associate Director
Dana-Farber Cancer Institute
Kumar Srinivasan Kumar Srinivasan
VP, Scientific Partnering and Alliances
Henri Termeer Henri Termeer
Former CEO, President and Chairman
Genzyme Corporation
S. Edward Torres S. Edward Torres
Co-Founder and Managing Director
Lilly Ventures
Robert Urban Robert Urban
Johnson & Johnson Innovation Boston
Geeta Vemuri Geeta Vemuri
Managing Partner
Baxalta Ventures
Rupert Vessey Rupert Vessey
Senior VP, Translational Development
Christopher A Viehbacher Christopher A Viehbacher
Managing Partner
Gurnet Point Capital
Geoffrey   von Maltzahn Geoffrey von Maltzahn
VentureLabs Partner
Flagship Ventures
Daphne Zohar Daphne Zohar
Founder, Managing Partner
PureTech Ventures
Arrow Up

© 2009–2015 EBD Group, Inc.